Application

15146045 · TARGETING OF INNATE IMMUNE RESPONSE TO TUMOR SITE

Filed 2016-05-04 · Granted · Patent 10188741 (2019-01-29) The official file ↗The patent and its PDF ↗ · Art unit 1645 · Examiner Lakia J Jackson-Tongue Typical · CPC A61K 47/6807 · HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT · FisherBroyles, LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.5 mo

to disposition 32.9 mo

Statutes raised

102 103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.